Regulatory mechanism of MicroRNA expression in cancer

Z Ali Syeda, SSS Langden, C Munkhzul, M Lee… - International journal of …, 2020 - mdpi.com
Altered gene expression is the primary molecular mechanism responsible for the
pathological processes of human diseases, including cancer. MicroRNAs (miRNAs) are …

The regulatory role of micro RNA s in angiogenesis‐related diseases

LL Sun, WD Li, FR Lei, XQ Li - Journal Of Cellular And …, 2018 - Wiley Online Library
Micro RNA s (mi RNA s) are small non‐coding RNA s that regulate gene expression at a
post‐transcriptional level via either the degradation or translational repression of a target …

miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review

MT Di Martino, M Arbitrio, D Caracciolo… - … Therapy-Nucleic Acids, 2022 - cell.com
Among deregulated microRNAs (miRs) in human malignancies, miR-221 has been widely
investigated for its oncogenic role and as a promising biomarker. Moreover, recent evidence …

Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling

Y Tang, J Pan, S Huang, X Peng, X Zou, Y Luo… - Journal of Experimental …, 2018 - Springer
Background Bone metastasis is a leading cause of morbidity and mortality in advanced
prostate cancer (PCa). Downexpression of miR-133a-3p has been found to contribute to the …

SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein

C Geng, S Kaochar, M Li, K Rajapakshe, W Fiskus… - Oncogene, 2017 - nature.com
The E3 ubiquitin ligase adaptor speckle-type POZ protein (SPOP) is frequently dysregulated
in prostate adenocarcinoma (PC), via either somatic mutations or mRNA downregulation …

MicroRNAs in cancer metastasis: biological and therapeutic implications

MC Sell, CA Ramlogan-Steel, JC Steel… - Expert Reviews in …, 2023 - cambridge.org
Cancer metastasis is the primary cause of cancer-related deaths. The seeding of primary
tumours at a secondary site is a highly inefficient process requiring substantial alterations in …

Therapeutic targeting of MicroRNAs in the tumor microenvironment

R Raue, AC Frank, SN Syed, B Brüne - International journal of molecular …, 2021 - mdpi.com
The tumor-microenvironment (TME) is an amalgamation of various factors derived from
malignant cells and infiltrating host cells, including cells of the immune system. One of the …

[HTML][HTML] The androgen receptor expression and association with patient's survival in different cancers

C Hu, D Fang, H Xu, Q Wang, H Xia - Genomics, 2020 - Elsevier
To understand the androgen receptor (AR) in different human malignancies, we conducted a
pan-cancer analysis of AR in different tumor tissues and association with patient survival …

Androgen receptor signaling inhibitors: post-chemotherapy, pre-chemotherapy and now in castration-sensitive prostate cancer

N Mitsiades, S Kaochar - Endocrine-Related Cancer, 2021 - erc.bioscientifica.com
Based on pioneering work by Huggins, Hodges and others, hormonal therapies have been
established as an effective approach for advanced prostate cancer (PC) for the past eight …

[HTML][HTML] MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy

Z Cao, J Qiu, G Yang, Y Liu, W Luo, L You… - Cancer biology & …, 2020 - ncbi.nlm.nih.gov
MicroRNAs (miRNAs) are evolutionarily conserved small non-coding RNAs that affect
posttranscriptional regulation by binding to the 3′-untranslated region of target messenger …